Back to Search
Start Over
BioMarin's vosoritide granted orphan status for short stature in Noonan syndrome
- Source :
- The Fly. October 11, 2024
- Publication Year :
- 2024
-
Abstract
- BioMarin's vosoritide was granted FDA orphan status as a treatment of short stature in Noonan syndrome, according to a post to the agency's website. [Reference [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.811897539